BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34545207)

  • 21. Ubiquitination-mediated degradation of SIRT1 by SMURF2 suppresses CRC cell proliferation and tumorigenesis.
    Yu L; Dong L; Li H; Liu Z; Luo Z; Duan G; Dai X; Lin Z
    Oncogene; 2020 May; 39(22):4450-4464. PubMed ID: 32361710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CircAGFG1 drives metastasis and stemness in colorectal cancer by modulating YY1/CTNNB1.
    Zhang L; Dong X; Yan B; Yu W; Shan L
    Cell Death Dis; 2020 Jul; 11(7):542. PubMed ID: 32681092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CRHR2/Ucn2 signaling is a novel regulator of miR-7/YY1/Fas circuitry contributing to reversal of colorectal cancer cell resistance to Fas-mediated apoptosis.
    Pothoulakis C; Torre-Rojas M; Duran-Padilla MA; Gevorkian J; Zoras O; Chrysos E; Chalkiadakis G; Baritaki S
    Int J Cancer; 2018 Jan; 142(2):334-346. PubMed ID: 28929494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YY1-Induced Upregulation of Long Noncoding RNA ARAP1-AS1 Promotes Cell Migration and Invasion in Colorectal Cancer Through the Wnt/β-Catenin Signaling Pathway.
    Ye Y; Gu B; Wang Y; Shen S; Huang W
    Cancer Biother Radiopharm; 2019 Oct; 34(8):519-528. PubMed ID: 31173500
    [No Abstract]   [Full Text] [Related]  

  • 25. TMEM97 is transcriptionally activated by YY1 and promotes colorectal cancer progression via the GSK-3β/β-catenin signaling pathway.
    Mao D; Zhang X; Wang Z; Xu G; Zhang Y
    Hum Cell; 2022 Sep; 35(5):1535-1546. PubMed ID: 35907137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smurf2 induces ubiquitin-dependent degradation of Smurf1 to prevent migration of breast cancer cells.
    Fukunaga E; Inoue Y; Komiya S; Horiguchi K; Goto K; Saitoh M; Miyazawa K; Koinuma D; Hanyu A; Imamura T
    J Biol Chem; 2008 Dec; 283(51):35660-7. PubMed ID: 18927080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of CNKSR2 protein stability by the HECT E3 ubiquitin ligase Smurf2, and its role in breast cancer progression.
    David D; Surendran A; Thulaseedharan JV; Nair AS
    BMC Cancer; 2018 Mar; 18(1):284. PubMed ID: 29534682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The HECT ubiquitin E3 ligase Smurf2 degrades μ-opioid receptor 1 in the ubiquitin-proteasome system in lung epithelial cells.
    Dong S; Liu J; Li L; Wang H; Ma H; Zhao Y; Zhao J
    Am J Physiol Cell Physiol; 2019 May; 316(5):C632-C640. PubMed ID: 30758996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E3 ubiquitin ligase Smurf2: a prognostic factor in microsatellite stable colorectal cancer.
    Klupp F; Giese C; Halama N; Franz C; Lasitschka F; Warth A; Schmidt T; Kloor M; Ulrich A; Schneider M
    Cancer Manag Res; 2019; 11():1795-1803. PubMed ID: 30863185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the expression of
    Lu W; Yang C; He H; Liu H
    Int J Biol Sci; 2020; 16(6):1071-1085. PubMed ID: 32140074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ubiquitin ligase SMURF2 enhances epidermal growth factor receptor stability and tyrosine-kinase inhibitor resistance.
    Ray P; Raghunathan K; Ahsan A; Allam US; Shukla S; Basrur V; Veatch S; Lawrence TS; Nyati MK; Ray D
    J Biol Chem; 2020 Sep; 295(36):12661-12673. PubMed ID: 32669362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRTAC1 (Cartilage acidic protein 1) inhibits cell proliferation, migration, invasion and epithelial-mesenchymal transition (EMT) process in bladder cancer by downregulating Yin Yang 1 (YY1) to inactivate the TGF-β pathway.
    Yang J; Fan L; Liao X; Cui G; Hu H
    Bioengineered; 2021 Dec; 12(2):9377-9389. PubMed ID: 34818994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
    Wang J; Zhao X; Jin L; Wu G; Yang Y
    Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of transcription factor Yin Yang-1 in colorectal cancer.
    Shao Z; Yang W; Meng X; Li M; Hou P; Li Z; Chu S; Zheng J; Bai J
    Cancer Med; 2023 May; 12(10):11177-11190. PubMed ID: 36880159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CHIP/Stub1 functions as a tumor suppressor and represses NF-κB-mediated signaling in colorectal cancer.
    Wang Y; Ren F; Wang Y; Feng Y; Wang D; Jia B; Qiu Y; Wang S; Yu J; Sung JJ; Xu J; Zeps N; Chang Z
    Carcinogenesis; 2014 May; 35(5):983-91. PubMed ID: 24302614
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protein stability of Axin, a negative regulator of Wnt signaling, is regulated by Smad ubiquitination regulatory factor 2 (Smurf2).
    Kim S; Jho EH
    J Biol Chem; 2010 Nov; 285(47):36420-6. PubMed ID: 20858899
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Positive Feedback Loop of lncRNA MIR31HG-miR-361-3p -YY1 Accelerates Colorectal Cancer Progression Through Modulating Proliferation, Angiogenesis, and Glycolysis.
    Guo T; Liu D; Peng S; Wang M; Li Y
    Front Oncol; 2021; 11():684984. PubMed ID: 34485123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression.
    Zhang YL; Cao JL; Zhang Y; Liao L; Deng L; Yang SY; Hu SY; Ning Y; Zhang FL; Li DQ
    Med Oncol; 2022 Feb; 39(4):48. PubMed ID: 35103856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-suppressive role of Smad ubiquitination regulatory factor 2 in patients with colorectal cancer.
    Sato N; Sakai N; Furukawa K; Takayashiki T; Kuboki S; Takano S; Ohira G; Miyauchi H; Matsubara H; Ohtsuka M
    Sci Rep; 2022 Mar; 12(1):5495. PubMed ID: 35361871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.